X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1013) 1013
Publication (164) 164
Book Review (3) 3
Book Chapter (2) 2
Data Set (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (826) 826
humans (757) 757
male (657) 657
female (607) 607
obesity (531) 531
intra-abdominal fat - metabolism (519) 519
endocrinology & metabolism (448) 448
middle aged (389) 389
adult (378) 378
insulin resistance (361) 361
animals (349) 349
insulin-resistance (340) 340
metabolic syndrome (266) 266
risk factors (236) 236
nutrition & dietetics (232) 232
intra-abdominal fat - pathology (230) 230
body mass index (222) 222
adipose tissue (200) 200
obesity - metabolism (200) 200
adipose-tissue (194) 194
adipose tissues (193) 193
inflammation (188) 188
aged (182) 182
mice (172) 172
glucose (163) 163
research (162) 162
adiposity (156) 156
diabetes (141) 141
insulin (137) 137
metabolism (136) 136
intra-abdominal fat - drug effects (134) 134
physiological aspects (134) 134
rats (128) 128
subcutaneous fat - metabolism (128) 128
adiponectin (125) 125
adipocytes (120) 120
rodents (119) 119
research article (117) 117
gene expression (116) 116
visceral fat (116) 116
health aspects (115) 115
expression (110) 110
abridged index medicus (109) 109
article (105) 105
intra-abdominal fat - diagnostic imaging (104) 104
blood glucose - metabolism (101) 101
medicine (101) 101
obesity - pathology (101) 101
type 2 diabetes (101) 101
body composition (98) 98
obesity - physiopathology (97) 97
intra-abdominal fat (95) 95
secretion (95) 95
insulin - blood (94) 94
obesity - complications (94) 94
intra-abdominal fat - physiopathology (93) 93
multidisciplinary sciences (91) 91
young adult (91) 91
insulin sensitivity (90) 90
cross-sectional studies (86) 86
leptin (86) 86
body fat (85) 85
body weight (85) 85
cardiovascular-disease (85) 85
physiology (85) 85
adipocytes - metabolism (84) 84
glucose tolerance test (84) 84
adolescent (83) 83
gene-expression (83) 83
analysis (82) 82
lipids (80) 80
waist circumference (80) 80
mice, inbred c57bl (78) 78
insulin - metabolism (77) 77
liver - metabolism (77) 77
risk-factors (77) 77
adiponectin - blood (76) 76
obesity - blood (76) 76
science (76) 76
insulin resistance - physiology (74) 74
tomography, x-ray computed (74) 74
adipose tissue - metabolism (73) 73
nutritional and metabolic diseases (69) 69
cytokines (68) 68
diet (68) 68
metabolic disorders (67) 67
disease (66) 66
fat (66) 66
endocrinology (65) 65
genetic aspects (65) 65
intra-abdominal fat - immunology (65) 65
rna, messenger - metabolism (65) 65
intra-abdominal fat - cytology (64) 64
resistance (64) 64
sensitivity (64) 64
women (64) 64
obesity - genetics (63) 63
weight-loss (63) 63
case-control studies (62) 62
leptin - blood (62) 62
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology, ISSN 0013-7227, 01/2018, Volume 159, Issue 1, pp. 227 - 237
The prevalence of primary aldosteronism is much higher than previously thought. Recent studies have shown that primary aldosteronism is related to a higher... 
C-REACTIVE PROTEIN | CELLS | METABOLIC SYNDROME | INSULIN-RESISTANCE | BROWN ADIPOCYTES | ENDOCRINOLOGY & METABOLISM | CLINICAL-PRACTICE GUIDELINE | DIFFERENTIATION | DYSFUNCTION | HYPERTENSION | EXPRESSION | Adenoma - surgery | Adipocytes, Brown - metabolism | Adipokines - secretion | Stromal Cells - pathology | Humans | Middle Aged | Essential Hypertension - complications | Male | Adipocytes, Brown - immunology | Intra-Abdominal Fat - secretion | Adenoma - complications | Hyperaldosteronism - etiology | Subcutaneous Fat, Abdominal - immunology | Female | Panniculitis - immunology | Adipogenesis | Endothelium, Vascular - immunology | Intra-Abdominal Fat - immunology | Adipocytes, Brown - pathology | Panniculitis - etiology | Stromal Cells - metabolism | Cells, Cultured | Aldosterone - secretion | Stromal Cells - immunology | Adipokines - metabolism | Subcutaneous Fat, Abdominal - secretion | 3T3-L1 Cells | Intra-Abdominal Fat - metabolism | Adrenalectomy | Adenoma - physiopathology | Stromal Cells - secretion | Animals | Subcutaneous Fat, Abdominal - pathology | Adipocytes, Brown - secretion | Endothelium, Vascular - metabolism | Endothelium, Vascular - secretion | Adenoma - secretion | Fibrosis | Endothelium, Vascular - pathology | Mice | Intra-Abdominal Fat - pathology | Panniculitis - pathology | Subcutaneous Fat, Abdominal - metabolism | Panniculitis - metabolism | Adipose tissues | Hypertension | Adipose tissue | Genes | Interleukin | Health risks | Preadipocytes | Inflammation | Laparoscopy | Adenoma | Tumor necrosis factor-α | Aldosterone | Gene expression | Tissues | Patients | Interleukin 6 | Studies | Ribonucleic acids | Surgery | Cardiovascular diseases | Tumors | Cell differentiation
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 01/2015, Volume 55, Issue 12, pp. 2532 - 2540
Prolonged niacin treatment elicits beneficial effects on the plasma lipid and lipoprotein profile that is associated with a protective CVD risk profile. Acute... 
Polyunsaturated fatty acid | Fatty acid/biosynthesis | Adipocytes | Cytochrome P450 | Drug therapy/hypolipidemic drugs | Omega-3 fatty acids | NICOTINIC-ACID INFUSION | drug therapy | ESTER TRANSFER PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | fatty acid | omega-3 fatty acids | FATTY-ACIDS | cytochrome P450 | ACUTE CORONARY SYNDROME | HUMAN SKELETAL-MUSCLE | hypolipidemic drugs | SOLUBLE EPOXIDE HYDROLASE | DOCOSAHEXAENOIC ACID | INSULIN-RESISTANCE | biosynthesis | MICE | adipocytes | polyunsaturated fatty acid | EXTENDED-RELEASE NIACIN | Oxylipins - blood | Arachidonic Acid - metabolism | Hyperlipidemias - blood | Arachidonic Acid - blood | Gene Expression Profiling | Intra-Abdominal Fat - secretion | Niacin - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Liver - immunology | Niacin - therapeutic use | Liver - drug effects | Time Factors | Cholesterol Ester Transfer Proteins - genetics | Female | Intra-Abdominal Fat - drug effects | Hyperlipidemias - immunology | Arachidonic Acid - secretion | Biomarkers - metabolism | Intra-Abdominal Fat - immunology | Fatty Acids, Unsaturated - secretion | Fatty Acids, Omega-3 - metabolism | Hydroxylation | Hyperlipidemias - metabolism | Hyperlipidemias - drug therapy | Liver - metabolism | Mice, Transgenic | Biomarkers - blood | Fatty Acids, Unsaturated - metabolism | Apolipoprotein E3 - metabolism | Hypolipidemic Agents - pharmacology | Intra-Abdominal Fat - metabolism | Diet, Western - adverse effects | Gene Expression Regulation - drug effects | Docosahexaenoic Acids - secretion | Fatty Acids, Unsaturated - blood | Oxylipins - metabolism | Apolipoprotein E3 - genetics | Algorithms | Animals | Docosahexaenoic Acids - blood | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Fatty Acids, Omega-3 - blood | Fatty Acids, Omega-3 - secretion | Hypolipidemic Agents - therapeutic use | Cholesterol Ester Transfer Proteins - metabolism | Docosahexaenoic Acids - metabolism
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 09/2014, Volume 112, Issue 6, pp. 1034 - 1040
Journal Article
European Journal of Nutrition, ISSN 1436-6207, 4/2014, Volume 53, Issue 3, pp. 951 - 961
To evaluate the long-term consequences of TNFα inhibitors on body composition and fat distribution, as well as changes in serum adipokines in patients with... 
Chemistry | Nutrition | Cardiovascular risk | TNFα inhibitors | Adipokines | Fat mass | Body composition | Resistin | BONE-DENSITY | METABOLIC SYNDROME | RISK-FACTORS | BODY-COMPOSITION | ANKYLOSING-SPONDYLITIS | ADIPONECTIN LEVELS | TUMOR-NECROSIS-FACTOR | NUTRITION & DIETETICS | TNF alpha inhibitors | INSULIN-RESISTANCE | CARDIOVASCULAR-DISEASE | ADIPOSE-TISSUE | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Abdominal Fat - immunology | Antibodies, Monoclonal - adverse effects | Resistin - secretion | Antibodies, Monoclonal - therapeutic use | Male | Abdominal Fat - secretion | Adiponectin - antagonists & inhibitors | Spondylitis, Ankylosing - immunology | Arthritis, Rheumatoid - metabolism | Arthritis, Rheumatoid - drug therapy | Adiponectin - secretion | Adult | Female | Weight Gain - drug effects | Intra-Abdominal Fat - drug effects | Body Mass Index | Intra-Abdominal Fat - immunology | Abdominal Fat - pathology | Adiposity - drug effects | Spondylitis, Ankylosing - drug therapy | Insulin Resistance | Immunoglobulin G - therapeutic use | Abdominal Fat - drug effects | Spondylitis, Ankylosing - metabolism | Arthritis, Rheumatoid - pathology | Immunoglobulin G - adverse effects | Adiponectin - blood | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Resistin - blood | Intra-Abdominal Fat - pathology | Arthritis, Rheumatoid - immunology | Drug Monitoring | Resistin - antagonists & inhibitors | Spondylitis, Ankylosing - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 2016, Volume 231, Issue 2, pp. 109 - 120
Obesity is a risk factor that promotes progressive kidney disease. Studies have shown that an adipocytokine imbalance contributes to impaired renal function in... 
Adipocytokine | Visceral fat | Podocytopathy | Adipocytes | High-fat diet | adipocytokine | METABOLIC SYNDROME | ALBUMINURIA | ABDOMINAL OBESITY | OBESITY-RELATED GLOMERULOPATHY | ADIPONECTIN | INSULIN-RESISTANCE | high-fat diet | IMAGE-ANALYSIS | ENDOCRINOLOGY & METABOLISM | podocytopathy | HEMODIALYSIS-PATIENTS | CHRONIC KIDNEY-DISEASE | adipocytes | visceral fat | CARDIOVASCULAR RISK-FACTORS | Biomarkers - urine | Kidney Cortex - metabolism | Renal Insufficiency, Chronic - diagnostic imaging | Diet, High-Fat - adverse effects | Kidney Cortex - physiopathology | Male | Intra-Abdominal Fat - secretion | Renal Insufficiency, Chronic - metabolism | Adiposity | Obesity - etiology | Disease Models, Animal | Biomarkers - metabolism | Cell Line | Microscopy, Electron, Transmission | Kidney Cortex - ultrastructure | Podocytes - metabolism | Gene Expression Regulation | Insulin Resistance | Organ Size | Kidney Cortex - pathology | Obesity - physiopathology | Adipocytes, White - secretion | Biomarkers - blood | Podocytes - pathology | 3T3-L1 Cells | Intra-Abdominal Fat - metabolism | Rats, Sprague-Dawley | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Renal Insufficiency, Chronic - pathology | Culture Media, Conditioned | Podocytes - ultrastructure | Adipocytes, White - pathology | Animals | Mice | Intra-Abdominal Fat - pathology | Adipocytes, White - metabolism
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2013, Volume 98, Issue 7, pp. E1181 - E1188
Journal Article
Steroids, ISSN 0039-128X, 11/2012, Volume 77, Issue 13, pp. 1359 - 1365
Journal Article
Journal Article
Applied Physiology, Nutrition, and Metabolism, ISSN 1715-5312, 2017, Volume 42, Issue 2, pp. 181 - 192
Even though ellagic acid has previously been valued in many models of cancer, so far its full mechanistic effect as a natural antiapoptotic agent in the... 
repaglinide | répaglinide | type 2 diabetic rats | diabète de type 2 | ellagic acid | rats | insulin resistance | insulinorésistance | acide ellagique | Insulin resistance | Repaglinide | Type 2 diabetic rats | Ellagic acid | SPORT SCIENCES | PHYSIOLOGY | HIGH-FAT DIET | COLON CARCINOGENESIS | GLUCOSE-LEVELS | MELLITUS | IN-VITRO | NUTRITION & DIETETICS | INHIBITION | PATHWAY | SOLUBLE RAGE | NF-KAPPA-B | HEPATIC-ENCEPHALOPATHY | Rats, Wistar | Apoptosis - drug effects | Male | Diabetes Mellitus, Type 2 - metabolism | Intra-Abdominal Fat - secretion | Liver - physiopathology | Brain - metabolism | Liver - immunology | Liver - drug effects | Diabetes Mellitus, Type 2 - immunology | Inflammation Mediators - metabolism | Intra-Abdominal Fat - drug effects | Neurons - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Drug Therapy, Combination | Neurons - drug effects | Pancreas - secretion | Hypoglycemic Agents - therapeutic use | Intra-Abdominal Fat - immunology | Hyperglycemia - prevention & control | Ellagic Acid - therapeutic use | Liver - metabolism | Inflammation Mediators - blood | Insulin Resistance | Neurons - immunology | Pancreas - drug effects | Biomarkers - blood | Pancreas - metabolism | Intra-Abdominal Fat - metabolism | Pancreas - immunology | Brain - drug effects | Animals | Diabetes Mellitus, Type 2 - physiopathology | Piperidines - therapeutic use | Oxidative Stress - drug effects | Carbamates - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Brain - immunology | Type 2 diabetes | Care and treatment | Research | Health aspects
Journal Article
Experimental and Clinical Endocrinology & Diabetes, ISSN 0947-7349, 11/2012, Volume 120, Issue 10, pp. 611 - 617
Abstract Background: The growing family of C1Q/TNF-related proteins is characterized by structural homologies to the anti-inflammatory adipokine adiponectin.... 
Article | adipose tissue | lipolysis | adipokine | inflammation | CTRP-3 | CHROMOSOMAL LOCALIZATION | COLLAGENOUS REPEAT | GENOMIC ORGANIZATION | TISSUE | REPEAT-CONTAINING SEQUENCE | ADIPOSE CELL LINE | PROMOTES PROLIFERATION | 26-KDA PROTEIN | ENDOCRINOLOGY & METABOLISM | PPAR-GAMMA | TRANSCRIPTIONAL REGULATION | Tumor Necrosis Factors - genetics | Diabetes Mellitus, Type 2 - microbiology | Humans | Resistin - secretion | Diabetes Mellitus, Type 2 - metabolism | Intra-Abdominal Fat - secretion | Subcutaneous Fat - immunology | Subcutaneous Fat - metabolism | Subcutaneous Fat - secretion | Adipokines - genetics | Diabetes Mellitus, Type 2 - immunology | Female | Staphylococcal Infections - microbiology | Intra-Abdominal Fat - immunology | Recombinant Proteins - metabolism | Recombinant Proteins - antagonists & inhibitors | Resistin - metabolism | Staphylococcal Infections - immunology | Cells, Cultured | Gene Expression Regulation | Gene Silencing | Tumor Necrosis Factors - metabolism | Adipokines - metabolism | 3T3-L1 Cells | Intra-Abdominal Fat - metabolism | Subcutaneous Fat - pathology | Blotting, Western | Lipolysis | Adipokines - antagonists & inhibitors | Insulin - metabolism | Animals | Staphylococcus aureus - immunology | Mice | Diabetes Mellitus, Type 2 - pathology | Intra-Abdominal Fat - pathology | Epinephrine - metabolism | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article